THE BREAST CANCER RESEARCH FOUNDATION expanded its research program with a new collaborative breast cancer funding model, the BCRF Investigator-Initiated Drug Research Program. The received a three-year, $15 million grant from Pfizer to support this effort, as well as access to Pfizer’s portfolio of products. “It will encourage more creative, academic-driven research and give more...
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe